Top

Published in:

01-01-2013 | Review

Drug-related problem in children with chronic kidney disease

Authors: Norkasihan Ibrahim, Ian CK Wong, Susan Patey, Stephen Tomlin, Manish D Sinha, Yogini Jani

Published in: Pediatric Nephrology | Issue 1/2013

Abstract

Drug therapies in the management of chronic kidney disease (CKD) are complex and specialised and have a high potential for drug-related problem (DRP). In adult CKD populations, the identification and resolution of DRP has been shown to have beneficial effects on disease management, adherence and knowledge of treatment, patient’s quality of life, hospitalisation rate and length of stay and cost to the healthcare system. The focus of this article is the review of published studies on DRP in children with CKD. There is a lack of information on the epidemiology of DRP in this patient group, and research in this area is therefore needed to better understand and manage DRP in children with CKD.

Lewis MA, Shaw J, Sinha MD, Adalat S, Hussain F, Castledine C, van Schalkwyk D, Inward C (2009) Demography of the UK paediatric renal replacement therapy population in 2008. In: 12th report of UK Renal Registry. Available at: http://www.renalreg.com/Report-Area/Report%202008/Chapter14.pdf. Accessed 27 Mar 2011

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2010) United States Renal Data System, USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Available at: http://www.usrds.org/atlas.htm. Accessed 27 Mar 2011

Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2011) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363–373PubMedCrossRef

Warady BA, Chadha V (2007) Chronic kidney disease in children: the global perspective. Pediatr Nephrol 22:1999–2009PubMedCrossRef

Kaplan B, Mason NA, Shimp LA, Ascione FJ (1994) Chronic hemodialysis patients. Part I: characterization and drug-related problems. Ann Pharmacother 28:316–319PubMed

Manley HJ, Drayer DK, Muther RS (2003) Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrol 4:1–7CrossRef

Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ (2010) Medication-related problems in CKD. Adv Chronic Kidney Dis 17:404–412PubMedCrossRef

Grabe DW, Low CL, Bailie GR, Eisele G (1997) Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 47:117–121PubMed

Kaplan B, Mason NA, Shimp LA, Ascione FJ (1994) Chronic hemodialysis patients. Part II: reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother 28:320–324PubMed

10.

Tozawa M, Iseki K, Iseki C, Oshiro S, Higashiuesato Y, Yamazato M, Tomiyama N, Tana T, Takishita S (2002) Analysis of drug prescription in chronic haemodialysis patients. Nephrol Dial Transplant 17:1819–1824PubMedCrossRef

11.

Mirkov S (2009) Implementation of a pharmacist medication review clinic for haemodialysis patients. N Z Med J 122:25–37PubMed

12.

Sathvik BS, Mangasuli S, Narahari MG, Gurudev KC, Parthasarathi G (2007) Medication knowledge of hemodialysis patients and influence of clinical pharmacist provided education on their knowledge. Indian J Pharm Sci 69:232–239CrossRef

13.

Pai AB, Boyd A, Chavez A, Manley HJ (2009) Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study. Hemodial Int 13:72–79PubMedCrossRef

14.

Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H (2009) Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy 29:1433–1440PubMedCrossRef

15.

Manley HJ, Carroll CA (2002) The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 15:45–49PubMedCrossRef

16.

Pharmaceutical Care Network Europe (2010) Classification for drug-related problems: version 6.2 (14-10-2010)'. Available at: http://www.pcne.org/sig/drp/documents/drp/PCNE%20classification%20V6-2.pdf. Accessed 7 April 2011

17.

Frommer M, Rubin G, Lyle D (1992) The NSW health outcomes program. N S W Public Health Bull 3:135CrossRef

18.

Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD (1990) Drug-related problems: their structure and function. Drug Intel Clin Pharm 24:1093–1097

19.

Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients. Results of the Harvard medical practice study II. N Engl J Med 324:377–384PubMedCrossRef

20.

Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259PubMedCrossRef

21.

Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW (2004) Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 13:306–314PubMedCrossRef

22.

So TY, Layton JB, Bozik K, Farrington E, Gipson PE, Gibson K, Primack W, Conley W 3rd, Gipson DS, Ferris M (2011) Cognitive pharmacy services at a pediatric nephrology and hypertension clinic. Renal Fail 33:19–25CrossRef

23.

Jani YH, Ghaleb MA, Marks SD, Cope J, Barber N, Wong IC (2008) Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic. J Pediatr 152:214–218PubMedCrossRef

24.

Perrier-Cornet E, Prot-Labarthe S, Bourdon O, Brion F (2010) Report of pharmaceutical care in a nephrology paediatric care unit. Pharm World Sci 32:259–259

25.

Lincenberg J, Lerner G, Robin A, Layfield S, Macdonald N, Fleischmann L, Gruskin A (1986) Improving compliance in adolescent CAPD patients. Am J Kidney Dis 8:A13–A13

26.

Atiyeh BA, Dabbagh SS, Gruskin AB (1996) Evaluation of renal function during childhood. Pediatr Rev 17:175–180PubMedCrossRef

27.

Brandt JR, Wong CS, Hanrahan JD, Qualls C, McAfee N, Watkins SL (2006) Estimating absolute glomerular filtration rate in children. Pediatr Nephrol 21:1865–1872PubMedCrossRef

28.

Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National kidney foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421PubMedCrossRef

29.

Kimland E, Bergman U, Lindemalm S, Böttiger Y (2007) Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr 166:527–532PubMedCrossRef

30.

Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77–83PubMedCrossRef

31.

Churchwell MD, Mueller BA (2007) Selected pharmacokinetic issues in patients with chronic kidney disease. Blood Purif 25:133–138PubMedCrossRef

32.

Chisholm-Burns MA, Spivey CA, Rehfeld R, Zawaideh M, Roe DJ, Gruessner R (2009) Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 9:2497–2504PubMedCrossRef

33.

Chisolm MA, Kwong WJ, Spivey CA (2007) Associations of characteristics of renal transplant recipients with clinician’s perceptions of adherence to immunosuppressant therapy. Transplantation 84:1145–1150CrossRef

34.

El Nahas M (2005) The global challenge of chronic kidney disease. Kidney Int 68:2918–2929PubMedCrossRef

Title: Drug-related problem in children with chronic kidney disease
Authors: Norkasihan Ibrahim
Ian CK Wong
Susan Patey
Stephen Tomlin
Manish D Sinha
Yogini Jani
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 1/2013
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-012-2149-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Drug-related problem in children with chronic kidney disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Hyponatremia in a child with Takayasu arteritis: Questions

Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab

Cystinosis: the evolution of a treatable disease

Cystic kidney diseases: many ways to form a cyst

Erratum to: Ambulatory blood pressure status in children: comparing alternate limit sources

Growth hormone improves growth in pediatric renal transplant recipients—a systemic review and meta-analysis of randomized controlled trials